Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Macular Degeneration: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Associated Genes | ABCA1, ABCA4, ABCA7, AGING, AKT, ALZHEIMER, ALZHEIMER DISEASE, ALZHEIMER'S DISEASE |
| KG Connections | 291 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
graph TD
Macular_Degeneration["Macular Degeneration"] -->|"therapeutic target"| Autophagy["Autophagy"]
Macular_Degeneration["Macular Degeneration"] -->|"therapeutic target"| Apoptosis["Apoptosis"]
Macular_Degeneration["Macular Degeneration"] -->|"associated"| Autophagy_1["Autophagy"]
Macular_Degeneration["Macular Degeneration"] -->|"regulates"| Differentiation["Differentiation"]
Macular_Degeneration["Macular Degeneration"] -->|"causes"| Epithelial_Mesenchymal_Transit["Epithelial-Mesenchymal Transition"]
Macular_Degeneration["Macular Degeneration"] -->|"causes"| Oxidative_Stress["Oxidative Stress"]
AUTOPHAGY["AUTOPHAGY"] -->|"therapeutic target"| Macular_Degeneration["Macular Degeneration"]
APOPTOSIS["APOPTOSIS"] -->|"therapeutic target"| Macular_Degeneration["Macular Degeneration"]
AUTOPHAGY_2["AUTOPHAGY"] -->|"activates"| Macular_Degeneration["Macular Degeneration"]
AUTOPHAGY_3["AUTOPHAGY"] -->|"associated"| Macular_Degeneration["Macular Degeneration"]
style Macular_Degeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Autophagy | therapeutic_target | pathway | 0.80 |
| Apoptosis | therapeutic_target | pathway | 0.80 |
| Oxidative Stress | causes | pathway | 0.70 |
| Epithelial-Mesenchymal Transition | causes | pathway | 0.70 |
| Autophagy | associated_with | pathway | 0.70 |
| Differentiation | regulates | pathway | 0.70 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Autophagy | activates | pathway | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Complement | associated_with | pathway | 0.60 |
| Phagocytosis | causes | pathway | 0.60 |
| Mitochondrial Function | causes | pathway | 0.60 |
| Mitophagy | causes | pathway | 0.60 |
| Oxidative Stress | interacts_with | pathway | 0.60 |
| Autophagy | causes | pathway | 0.60 |
| Senescence | therapeutic_target | pathway | 0.60 |
| Mtor | regulates | pathway | 0.60 |
| Oxidative Stress | activates | pathway | 0.60 |
| Mitochondrial Function | activates | pathway | 0.60 |
| Nf-Κb | activates | pathway | 0.60 |
| Senescence | causes | pathway | 0.60 |
| Ferroptosis | therapeutic_target | pathway | 0.60 |
| Oxidative Stress | therapeutic_target | pathway | 0.60 |
| Mitophagy | associated_with | pathway | 0.60 |
| Apoptosis | implicated_in | pathway | 0.60 |
| Pyroptosis | implicated_in | pathway | 0.60 |
| Mtor | associated_with | pathway | 0.60 |
| Synaptic Plasticity | regulates | pathway | 0.60 |
| Oxidative Stress | regulates | pathway | 0.60 |
| Oxidative Stress | associated_with | pathway | 0.60 |
| Mitochondrial Function | associated_with | pathway | 0.60 |
| Aging | associated_with | disease | 0.55 |
| Inflammation | associated_with | disease | 0.55 |
| Endocytosis | associated_with | pathway | 0.55 |
| Cancer | therapeutic_target | disease | 0.55 |
| Inflammation | interacts_with | disease | 0.55 |
| Mitophagy | regulates | pathway | 0.55 |
| Autophagy | regulates | pathway | 0.55 |
| Ferroptosis | regulates | pathway | 0.55 |
| Lymphoma | therapeutic_target | disease | 0.55 |
| Lipid Metabolism | activates | pathway | 0.55 |
| Cholesterol | activates | pathway | 0.55 |
| Inflammasome | activates | pathway | 0.55 |
| Retinopathy | associated_with | disease | 0.55 |
| Glaucoma | associated_with | disease | 0.55 |
| Nf-Κb | therapeutic_target | pathway | 0.55 |
| Cardiovascular | implicated_in | disease | 0.55 |
| Parkinson | associated_with | disease | 0.55 |
| Sarcopenia | associated_with | disease | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Stargardt'S Disease | associated_with | disease | 0.90 |
| Stargardt's Disease | involved_in | disease | 0.85 |
| AUTOPHAGY | therapeutic_target | gene | 0.85 |
| APOPTOSIS | therapeutic_target | gene | 0.85 |
| OXIDATIVE STRESS | causes | gene | 0.75 |
| BCL-2 | therapeutic_target | gene | 0.75 |
| LC3 | therapeutic_target | gene | 0.75 |
| ALZHEIMER | associated_with | gene | 0.75 |
| MITOCHONDRIA | associated_with | gene | 0.75 |
| AUTOPHAGY | associated_with | gene | 0.75 |
| AUTOPHAGY | activates | gene | 0.75 |
| INFLAMMATION | therapeutic_target | gene | 0.75 |
| TXNRD1 | causes | gene | 0.65 |
| PHAGOCYTOSIS | causes | gene | 0.65 |
| FERROPTOSIS | activates | gene | 0.65 |
| TFEB | regulates | gene | 0.65 |
| ATG4B | activates | gene | 0.65 |
| PI3K | causes | gene | 0.65 |
| MTORC1 | regulates | gene | 0.65 |
| CANCER | associated_with | gene | 0.65 |
| AKT | regulates | gene | 0.65 |
| ULK1 | regulates | gene | 0.65 |
| COMPLEMENT | associated_with | gene | 0.65 |
| MITOCHONDRIA | causes | gene | 0.65 |
| DIABETIC RETINOPATHY | associated_with | gene | 0.65 |
| GENES | interacts_with | gene | 0.65 |
| INFLAMMATION | interacts_with | gene | 0.65 |
| TOMM20 | activates | gene | 0.65 |
| PKC | regulates | gene | 0.65 |
| ATG | therapeutic_target | gene | 0.65 |
| ATG5 | therapeutic_target | gene | 0.65 |
| ALZHEIMER | therapeutic_target | gene | 0.65 |
| AMYLOID | therapeutic_target | gene | 0.65 |
| BCL2 | therapeutic_target | gene | 0.65 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.65 |
| LAMP1 | therapeutic_target | gene | 0.65 |
| MITOCHONDRIA | therapeutic_target | gene | 0.65 |
| NAD | therapeutic_target | gene | 0.65 |
| OXIDATIVE STRESS | interacts_with | gene | 0.65 |
| SIRT1 | therapeutic_target | gene | 0.65 |
| OXIDATIVE STRESS | therapeutic_target | gene | 0.65 |
| ARC | associated_with | gene | 0.65 |
| APOPTOSIS | implicated_in | gene | 0.65 |
| NEURODEGENERATION | implicated_in | gene | 0.65 |
| PYROPTOSIS | implicated_in | gene | 0.65 |
| NEURODEGENERATIVE DISORDERS | associated_with | gene | 0.65 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.65 |
| PINK1 | activates | gene | 0.65 |
| NFE2L2 | causes | gene | 0.65 |
| PARKIN | activates | gene | 0.65 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning Macular Degeneration in their description or question text
No additional research found